Iohexol compared to metrizamide in cervical and thoracic myelography
β Scribed by P. Nakstad; A. Helgetveit; O. Aaserud; T. Ganes; R. Nyberg-Hansen
- Publisher
- Springer
- Year
- 1984
- Tongue
- English
- Weight
- 517 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0028-3940
No coin nor oath required. For personal study only.
β¦ Synopsis
A randomized double blind study with iohexol (Omnipaque) and metrizamide (Amipaque) in cervical myelography was performed in 50 patients, 29 with iohexol and 21 with metrizamide. The myelographies were performed either with lumbar or with C1-C2 puncture in about equal groups, using 300 mg I/ml and 240 mg I/ml of the contrast media respectively. The image quality was equal with both contrast media, excellent in about 4/5 and good in 1/5 of the examinations. Subjective side effects were twice as frequent with metrizamide as with iohexol. The most frequent side effect was headache, occurring in 34% with iohexol and in 67% with metrizamide. Altogether 24% or the patients had EEG changes after iohexol as compared to 47% after metrizamide. All EEG changes were slight dysrythmia-except in three patients with spike activity after metrizamide. These were the only ones with mental reactions as well. It can be concluded that in this trial iohexol was better suited for cervical myelography than metrizamide.
π SIMILAR VOLUMES
To estimate the risk of developing cervical intra-epithelial neoplasia (CIN) among women exposed to human papillomavirus (HPV) type 16, we performed a prospective study in a population-based cohort of more than 15, OOO women followed for 34.9 months. Seventy-four women developed CIN during follow-up
## Abstract ## BACKGROUND Asian Americans have lower cancer screening rates compared with nonβHispanic whites (NHWs). Little is known about mechanisms that underlie disparities in cancer screening. The objectives of the current study were 1) to determine the relation between nativity, years in the
Cervical scrapes from 80 women with a positive cytology result were tested for the presence of human papillomavirus (HPV) using the polymerase chain reaction (PCR) and compared to the results obtained with the modified filter in situ hybridisation (FISH) and the Southern-blot techniques. The sensit